Luteolin has been found to be effective and exert an inhibitory effect on the proliferation, migration, and invasion of different cancers via acting on and altering the PI3K/AKT, mTOR (the mammalian target of rapamycin), ERK, and p38 signaling pathways and their associated molecules [62] (Figure 6). Here, MTOR is linked to cancer.